NL-OMON48207已完成不适用
*An interventional, randomized, double-blind, sequential-group, placebo-controlled, single-ascending oral dose study investigating the safety, tolerability, pharmacokinetic and pharmacodynamic properties of Lu AF95245 and open-label crossover study to investigate intra-subject variability, effect of food on Lu AF95245, and metabolic profile of [14C]-Lu AF95245 in healthy young men* - CS0329 Lundbeck (18193A)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy, young, non-smoking men *18 and *45 years of age and a body mass index
- •(BMI) *18.5kg/m2 and *30kg/m2 at the Screening Visit.
- •Please refer to the protocol for more inclusion criteria.
排除标准
- •The subject has any concurrent disorder that may affect the particular target
- •or absorption, distribution, or elimination of the IMP.
- •Please refer to the protocol for more exclusion criteria.
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate the cognitive effect of a product named vortioxetine (used in depression). These effects willbe compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.EUCTR2014-000229-19-FIH. Lundbeck A/S195
进行中（未招募）
1 期
A study to evaluate the cognitive effect of a product named vortioxetine (used in depression). These effects willbe compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.Major Depressive Disorder and cognitive impairmentMedDRA version: 17.1Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2014-000229-19-EEH. Lundbeck A/S195
进行中（未招募）
不适用
A study to evaluate the cognitive effect of a product named vortioxetine (used in depression) for patient with inadequate effect of other drugs for depression. These effects will be compared to those induced by a marketed comparator. Investigator and subjects will be blinded.Major Depressive Disorder and cognitive impairmentMedDRA version: 17.1Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2014-000231-16-DEH. Lundbeck A/S130
进行中（未招募）
1 期
A study to evaluate the cognitive effect of a product named vortioxetine (used in depression). These effects willbe compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.Major Depressive Disorder and cognitive impairmentMedDRA version: 17.0Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2014-000229-19-SKH. Lundbeck A/S195
进行中（未招募）
不适用
A study to evaluate the cognitive effect of a product named vortioxetine (used in depression) for patient with inadequate effect of other drugs for depression. These effects will be compared to those induced by a marketed comparator. Investigator and subjects will be blinded.EUCTR2014-000231-16-FIH. Lundbeck A/S130